Medicus Pharma (MDCX) Cash from Operations (2024 - 2025)

Medicus Pharma (MDCX) posted Cash from Operations of 6609115.0 for Q4 2025, up 2.2% quarter-over-quarter from 6757829.0 in Q3 2025, and down 107.08% year-on-year from 93328794.6 in Q4 2024.

Medicus Pharma (MDCX) Cash from Operations (2024 - 2025) Analysis & Trends

Medicus Pharma (MDCX) has reported Cash from Operations for 2 consecutive years, with 6609115.0 the latest figure, recorded in Q4 2025.

  • Cash from Operations for Q4 2025 came in at 6609115.0, down 107.08% year-over-year; the trailing twelve-month figure through Dec 2025 was 22776769.0 (down 122.27% YoY), and the FY2025 annual result was 22776769.0, down 122.27% from the prior year.
  • Cash from Operations was 6609115.0 for Q4 2025 at Medicus Pharma, up from 6757829.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 1176933.0 in Q1 2024 and troughed at 6757829.0 in Q3 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 5.33 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 2.51 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 3.83 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 3.92 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 2.19 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 2.54 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 2.62 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Medicus Pharma 6.91 Mn -1.69 Mn - -6.61 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -6.61 Mn
Dec 31, 2025 -6.61 Mn
Sep 30, 2025 -6.76 Mn
Sep 30, 2025 -6.76 Mn
Jun 30, 2025 -5.47 Mn
Jun 30, 2025 -5.47 Mn
Mar 31, 2025 -3.94 Mn
Mar 31, 2025 -3.94 Mn
Dec 31, 2024 -3.19 Mn
Dec 31, 2024 -3.19 Mn
Sep 30, 2024 -3.10 Mn
Sep 30, 2024 -3.10 Mn
Jun 30, 2024 -2.78 Mn
Jun 30, 2024 -2.78 Mn
Mar 31, 2024 -1.18 Mn
Mar 31, 2024 -1.18 Mn